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SulTlmary 
Recognition of self-antigens by T  lymphocytes is  a central event in autoimmunity.  Under- 
standing of the molecular interactions between T  cell receptors (TCR) and self-epitopes may 
explain how T  cells escape thymic education and initiate an autoimmune reaction. We have 
studied five human in vivo activated T  cell clones specific for the region 535-551  of human 
thyroid peroxidase (TPO) established from a Graves' patient. Three clones (37, 72, and 73) ex- 
pressed identical TCR [3 and et chains rearranging V[3 1.1  and Vet 15.1, and were considered 
sister clones. Clone 43 differed from clone 37 and its sisters in the Jet region only. Clone NP-7 
expressed V[3 6.5 but rearranged two in-frame TCR et chain, both using the Vet 22,1 segment. 
Fine epitope mapping using nested peptides showed that clones using identical TCR [3 chains, 
identical Vet, but a different Jot recognized distinct, nonoverlapping epitopes in the TPO 535- 
551 region. This finding shows that a different  Jet region alone leads to a heterogeneous pattern 
of recognition. This indicates that the "restricted" TCR V  region usage sometimes found in 
autoimmune diseases may not always  correspond to identical epitope recognition. To confirm 
that clones 37 (and its sisters) and 43 recognize different epitopes, the T  cell clones were stimu- 
lated with a TPO-transfected autologous Epstein-Barr virus (EBV)  cell line (TPO-EBV) that 
presents TPO epitopes after endogenous processing. Only clone 37 and its  sisters recognizes 
the TPO-EBV cell line, suggesting that the epitope recognized by clone 43 is not presented 
upon endogenous processing. We have shown that thyroid epithelial cells (TEC), the only cells 
that produce TPO, express HLA class II molecules in Graves' disease  and can act as antigen- 
presenting cells,  presenting TPO after endogenous processing to autoantigen-reactive T  cell 
clones. We tested, therefore, whether autologous TEC induced the same pattern of stimulation 
as TPO-EBV; T cell clone 37 recognizes the TEC, whereas it is stimulated poorly by the TPO 
loaded to autologous peripheral blood mononuclear cells  (PBMC).  Clone 43, which fails to 
recognize the TPO-EBV, also fails to recognize the TEC, but is activated by exogenous TPO 
presented by autologous PBMC. These results  show that exogenous versus endogenous pro- 
cessing in vivo generates a different TPO  epitope repertoire, producing a "cryptic" epitope 
(epitope not always available  for recognition). Our findings define a route by which human 
self-reactive T  cells may escape thymic selection and become activated in vivo, thus possibly 
leading to autoimmunity. 
A  major unsolved question is how self-reactive T  cells 
escape  thymic  selection to  reach  the  periphery,  and 
how under certain conditions they become activated, lead- 
ing to autoimmune diseases. A number of hypotheses have 
been proposed to explain these events, and recently it has 
become  apparent  that  the  overall  affinity/avidity  of the 
TCR-peptide-MHC  complex  dictates  thymic  selection 
(1).  For instance, such affinity/avidity may be reduced by 
two TCR expressed on the same T  cell surface (2, 3). Al- 
ternatively,  self-peptides  with  extremely low  affinity for 
their genetic restriction elements might not form a stable 
enough complex with MHC in the thymus, and thus per- 
mit self-reactive T  cells to escape negative selection (4, and 
Quaratino  et al.,  manuscript in preparation). Another hy- 
pothesis is based o~a the concept that different epitope rep- 
ertoires may be  processed and  presented under  different 
conditions or by distinct APC (5-7). 
Thus, the immune system may not usually see some im- 
portant  self-epitopes, which  are  considered to  be  cryptic 
since they are hidden during the essential  phases  of thymic 
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riphery, then autoimmunity could ensue (7, 8). The factors 
leading to  this  differential display are  not  totally defined, 
but it is now known that different arrays of epitopes can be 
generated if proteins  (such  as viral proteins)  are processed 
by the  endogenous  or exogenous  pathway  (9,  10).  How- 
ever, this has not yet been shown in human autoimmunity. 
Ultimately, whatever is the processing pathway, the ini- 
tiating event of an  immune  response is the recognition of 
the peptide fragment exposed in the NtHC binding groove 
by the TCR.  Many studies have attempted to characterize 
the TCR  usage,  epitope recognition, and HLA restriction 
of human  autoreactive  T  cells.  It  has  been  reported  that 
myelin  basic  protein  (MBP)l-specific  T  cells have  biased 
TCR  usage in humans  (11,  12)  and in mice (13),  and may 
dominantly recognize a specific region of MBP in the con- 
text of the same HLA molecule (14). In these studies, how- 
ever, there is no evidence that the T  cells studied were ei- 
ther  activated  in  vivo,  or  were  involved  in  the  disease 
process. This is because of the technical limitations of work 
with  human  pathologic material.  In  Graves'  disease  (GD) 
we have been able to overcome some of these limitations, 
as the cells studied were activated in vivo expressing the IL-2 
receptor,  and  were  cloned  without  exposure  to  antigen 
(15,  16).  Hence,  these cells may have greater relevance to 
disease than  T  cells cloned with antigen from PBMC,  for 
which there is no conclusive evidence of disease relevance, 
since similar clones can be generated from healthy individ- 
uals. Using this approach we found that a region of thyroid 
peroxidase (TPO)  amino acids 535-551  was recognized by 
a  significant proportion  (16%)  of in  vivo-activated T  cell 
clones (16). Thus we focused our attention on these clones. 
We describe below the TCR. sequence expressed by these 
T  cell clones,  the  core  epitope recognized,  and  the  HLA 
element of genetic restriction. Since thyroid epithelial cells 
(TEC) can act as APC in GD and present autoantigens to T 
cells,  after  endogenous  processing  (15-17),  we  used  a 
TPO-transfected  EBV  cell line  as  well  as  the  autologous 
TEC  to  stimulate  the  T  cell  clones  and  compared  them 
with  TPO  presented  after  exogenous  processing  by 
PBMC.  The differences observed between exogenous and 
endogenous processing demonstrate the existence ofT cells 
recognizing a cryptic epitope, an epitope otherwise hidden, 
which  can  be  a  strong  T  cell stimulator.  The  results  de- 
scribed  here  suggest  that  cryptic  self-determinants  gener- 
ated  by  atypical APC  may play an  important  role  in  the 
pathogenesis of autoinmmne diseases. 
Materials  and Methods 
T  Cell Clones.  T  cell clones were  established from  Graves' 
thyroid infiltrate in  absence  of antigen,  according to  our pub- 
lished  procedure  (15).  Briefly,  activated  thyroid-infiltrating T 
lymphocytes were  cultured in the presence of IL-2  (20  ng/ml, 
~Abbreviations used in this  paper: AnPCR, anchored PCR; G1), Graves' dis- 
ease; MBP, myelin basic  protein; TEC, thyroid epithelial  cell;  TPO, human 
thyroid peroxidase. 
kindly donated by Hoffmann-La Roche, Nutley, NJ) for 1 wk m 
RPMI 1640/10% human serum and then expanded for a further 
week with irradiated (4,500  rad) autologous peripheral blood leu- 
kocytes, OKT3 anti-CD3 mAb (30 ng/ml), and IL-2. Cells were 
cloned by limiting dilution in absence of any antigen as described 
(15,  16). The T cell clones were stimulated with irradiated feeder 
cells and PHA or with OKT3  coated to plastic and cultured in 
media consisting of RPMI 1640,  10% pooled human serum,  100 
U/ml penicillin, and 50  Ixg/ml streptomycin. Every 4-5 d,  ex- 
panding T cell clones were fed with 10 ng/ml oflL-2. 
Antigens.  Peptide TPO 535-551,  corresponding to amino acids 
535-551  of the  human  TPO  molecule  (LDPLIRGLLARPA- 
KLQ),  and  eight overlapping "nested"  synthetic peptides of 12 
amino acids spanning from residues 534  to 552  of human  TPO 
were gifts from Anergen (Redwood City, CA) and Chiron Mim- 
otopes (Clayton, Australia). 
T  Cell Proliferation Assay.  The  TPO  peptides  were  used  to 
define the minimum epitope specificity of each T cell clone. The 
T cell clones were tested at least 2 wk after the last TCR stimula- 
tion and 5 d after the last addition of IL-2. The reactivity to the 
TPO  534-552  synthetic  overlapping peptides  was  assessed  by 
coculturing 104 T  cells from each T cell clone with 3  ￿  104 glu- 
taraldehyde-fixed, autologous EBV-transformed PBMC  as APC 
(16).  The autologous EBV-transformed cell line was pulsed with 
or without 10 txg/ml of each of the peptides used in the assay for 
1 h at 37~  before incubation with T cells. All T cell clones were 
tested at least twice, and all the experiments showed a similar pro- 
file of responsiveness. 
T cell clones were also tested using autologous PBMC as APC. 
3 ￿  104 PBMC isolated from heparinized whole blood by buoy- 
ant  density  centrifugation  (Lymphoprep;  Nycomed  Pharma, 
Oslo, Norway) were irradiated (4,500  rad) and incubated with 25 
fxg/ml of recombinant human  TPO  expressed in Chinese ham- 
ster ovary (CHO) cells for 2 h before adding the T cell clones. 
When autologous TEC  were  used,  they were  obtained after 
enzymatic digestion of the thyroid and used in proliferative assays 
without addition of antigen as described (15). Briefly, TEC were 
irradiated as above and plated at 3  ￿  104/well and used to stinm- 
late the T cell clones plated at 104/well. All the proliferative assays 
were performed in triplicate for 72 h in a flat- or round-bottoln 
96-well microtiter plate and the cells were pulsed with [3Hlthy- 
midine (1  IxCi) during the last 8 h of culture. 
TCR GenetkRestriction.  Two  homozygous  EBV-transfonned 
B cell lines expressing identical DP2 or DQ6 with the autologous 
APC  were  selected from  the  10th  HLA  Workshop  to  define 
whether  the  element  of genetic  restriction was  DP2  or  DQ6. 
EBV  cell  line  9036  expressed DPBI*02012  and  DQB1*0502/ 
DQA*0102,  whereas  cell hne  9013  expressed  DPB1*0402  and 
DQB1*0602/DQA*0102.  3  ￿  104  gluteraldehyde-fixed EBVs 
were challenged with or without the TPO peptide 535-551  for 1 h 
before adding the T  cell clones. The experiment was performed 
in triplicate, and the cells were pulsed with [~H]thymidine during 
the last 8 h of the 72-h culture. 
PCR  Amplification  and  Sequence  Analysis  ~y-  TCR-oe  and  -[3 
eDNA.  Total RNA was extracted from  3-5  X  10  ~' cells by a 
modified  guanidine-isothiocyanate-phenol-chloroform  method 
and first-strand eDNA  was  synthesized by a standard oligo(dT) 
method,  using ~-'5 Ixg of total RNA  (18).  To  elicit maximum 
TCR  expression before RNA extraction and eliminate possible 
contamination by feeder cell RNA, resting T cells (more than 14 
d after last stimulation) were stimulated with immobilized OKT3 
for 24 h before harvesting for RNA preparation, eDNA encoding 
the TCR o~ and [3 chains were then amplified using the anchored 
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to the single-strand  cDNA with terminal deoxynucleotidyl trans- 
ferase in cobalt buffer (Boehringer-Mannheim Corp., Indianapolis, 
IN) and 0.1 mM dGTP for 30 rain at 37~  AnPCR was performed 
using  oligonucleotide primers  complementary to  the  poly(dG) 
(5'-CACTCGAGCGGCCGCGTCGACCCCCCCCCC-3') and 
to  either the  5'  end of ot constant region  (5'-GCGAATTCA- 
GATCTTAGGCAGACAGACTTG TCACTGG-3')  or  the  5' 
end  of 13 constant region  (5'-GCTCTAGAGTCG ACGGCT- 
GCTCAGGTCAGTATCTGGAGT-3'). Each DNA reaction mix- 
ture  containing 15 mM MgC12 and 50 pmol of each of the two 
oligo primers  was  subjected  to  25  cycles  of amplification  in  a 
thermal cycler (Perkin-Elmer Cetus Corp., Norwalk, CT) at the 
following temperatures: 93~  for 15 s, 55~  for 1 rain,  60~  for 
15  s,  and  72~  for 2  rain.  A  final  10-rain  extension  was  per- 
formed at 72~  to ensure  fully duplexed DNA for optimal liga- 
tion efficiency.  PCR products (~0.6-0.7 kb) were digested  with 
appropriate  restriction  enzymes and  isolated  from agarose  gels, 
subcloned into PUC19 vector, and sequenced according to the 
dideoxynucleotide  termination  method  (20).  Sequencing  was 
performed on both strands using the forward and reverse univer- 
sal  M13  primers.  Several  independent  colonies  (usually  five  to 
eight)  were sequenced to confirm the clonal nature of the T  cell 
clones,  to  exclude  base  misincorporations  due  to  PCR  errors 
(21), and to detect eventual functional rearrangements  of  both the 
ci loci in a single clone (19, 22).  Sequences obtained were com- 
pared to those of EMBL/GenBank/DDBJ  using the DNAStar  | 
software. 
Different RNA preparations  of the tested clones were analyzed 
for 2 yr. They were also tested  using a set of VI3 and Vet family- 
specific primers (23-25) as described  (18). The amplified products 
were purified from unincorporated primers and nucleotides and 
directly sequenced using a Dye deoxy terminator cycle sequenc- 
ing kit (Applied Biosystems,  Inc., a division  of Perkin-Elmer Ce- 
tus  Corp.,  Foster City,  CA) in an automatic sequencer  (model 
373 DNA Sequencing System; Applied Biosystems).  Each clone 
amplified  only one V[3 or Vet product, and was sequenced using 
5 pmol of the V[3 or Vot primers,  respectively.  PCR amplification 
was also performed incorporating 10 I.LCi  of [32p]dCTP, to detect 
eventual  amplified products imperceptible  after ethidium bromide 
staining  and UV visualization.  The gels were dried and exposed 
for 24 h on X-omat film (Eastman Kodak Co., Rochester, NY). 
TPO Transfection of Autologous EBV.  The  autologous  TPO- 
transfected  EBV-transformed B cell line was a kind gift of Dr. R. 
Mullins  (The Mathilda  & Terence Kennedy Institute  of Rheu- 
matology). The entire cDNA encoding the human TPO (3.1 kb, 
gift of Dr. B. Rapaport, University of California,  San Francisco, 
CA)  was  ligated  into  the  Asp718-HindlII  sites of the  vector 
pREP 4 (lnvitrogen, San Diego, CA), containing the Rous sar- 
coma virus  enhancer/promoter  and  the  hygromycin-resistance 
gene. Successfully transfected  cells were selected by growth in hy- 
gromycin-containing medium at a final concentration of 200 ~g/ 
ml  in  RPMI  1640  containing  10%  FCS  (26). An  autologous 
EBV-transformed B cell line  transfected  with the vector pREP- 
CAT, encoding the CAT protein, was used as control in the pro- 
liferative experiments. 
Results 
A panel of self-reactive T  cell clones specific for the 535- 
551 region of the human TPO antigen was raised from the 
thyroid infiltrate  of a patient with  autoimmune  thyroiditis 
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(GD).  These  clones  were  established  in  the  absence  of 
antigen  (15,  16),  reducing  the  bias  of in  vitro  antigen- 
driven expansion, and enabling analysis of a spontaneous in 
vivo  autoantigen-reactive  T  cell  response.  The  antigen 
specificity of all the clones was determined by their respon- 
siveness  to  exogenous  TPO,  processed  and  presented  by 
autologous PBMC (16). The epitope specificity of some of 
the  TPO-specific  T  cell  clones  was  further  characterized, 
and the TPO  region 535-551  was recognized by 6  out of 
81  clones  (16).  Five of these  clones have been analyzed in 
detail in this study. 
TCR  Analysis.  We  asked whether  the  similar  peptide 
specificity of the clones reflected a TCR  sequence similar- 
ity,  and whether there were any conserved amino acids in 
"motifs" at particular positions of their ix or 13 chains.  The 
cDNA corresponding to the  TCR  ix and  13  chains  of the 
five T  cell clones was amplified by the AnPCR technique 
and sequenced  (19).  The nucleotide and predicted protein 
sequences  spanning  the  junctional  V(D)J  regions  of the 
TCR  13 and ix chains of the five clones are shown in Fig. 1, 
A  and  B, respectively.  Clone NP-7 expressed V[3 6.5/D[3 
2.1/J[32.5,  whereas clones 72, 73, 37, and 43 expressed an 
identical TCR  [3 chain, V[3 1.1a/D[3 2.1/J[3 2.1  (Fig. 1 A). 
A  common motif was  observed in  the  CDR3  of these  [3 
chains  (Fig.  1  A):  at  position  101,  a  Glu  was  flanked  on 
both sides by polar uncharged residues  (Asn-Gln and Gln- 
Thr).  Alignment of the sequences showed that the  overall 
length  of the  presumptive  TCR  CDR3  loops  of clones 
bearing identical specificity differed in length by only one 
amino acid. 
We detected two "productive" ix chains in clone NP-7 
(Fig.  1 B): productive rearrangement  of both ix chain loci 
has been observed in up to 30% of both human and murine 
T  cells  (19, 22); two ix chains can be expressed on the sur- 
face of a single cell, pairing with the only 13 chain available 
(2,  3). The motif Gly-Asn (residues 95-96) observed in the 
two CDR3 of clone NP-7 was also detected in the CDR3 
of T  cell  clones  37,  72,  and  73.  The  sequences  of the  ix 
chains of clones 72, 73, and 37 were identical,  rearranging 
Vix  15.1/Jix  AC24.  Since  clones  37,  72,  and  73  express 
identical TC1K ix and 13 chains at the nucleotide level, they 
are sister clones. 
A  first AnPCR  analysis  of clone  43  indicated  the  pres- 
ence  of a  TCR  ix  chain  identical  to  one  of the  two  ix 
chains  of clone  NP-7.  To  exclude  cross-contaminations 
that occurred in manipulating clone 43,  T  cells  were sub- 
cloned by limiting dilution. We analyzed the TCR  of only 
a single subclone that functionally behaved in an identical 
way to the original one. The expression of only a single V[3 
and Vix was confirmed using a panel of 22 VI3 and 24 Vix 
family-specific primers  (Fig.  2).  Direct  sequencing  of the 
V~ amplified product confirmed the AnPCR analysis. The 
direct sequencing of the  only Vix  amplified  (Vix  15)  indi- 
cated that Jot IGR Ja08 was used instead of  Jix AC24, used 
by clone  37  and  its  sisters  (Fig.  1 B).  No Vix  22  product 
was amplified, indicating that the previous result was due to 
an  AnPCR  or  cellular  contamination.  We  also  used  the 
same  panel  of Vix  and  V[3  family-specific primers  to  test A 
Clone  Vl~  NDN  Jl~  CI~ 
101 
A  S  S  S  G  L  A  E  N  E  Q  Y  F  G  P  G  T  R  L  L  V  L 
72  GOCAGCAGC  TCA  GGACTAGCG G~  AATGAG  CAG  TAC  Trc GGG CCA  GGC ACG  CGG CTC CTG GTG  CTA 
A  S  S  S  G  L  A  E  N  E  Q  Y  F  G  P  G  T  R  L  L  V  L 
73  QCCAGCAGC  TCA GGACTA GCG C-~8  AAT  C-~G  CAG  TAC  TTC GGG CCA  GGC ACG  CGG CTC CTG GTG CTA 
A  S  S  S  G  L  A  E  N  E  Q  Y  F  G  P  G  T  R  L  L  V  L 
3 7  GIOCAGCAGC  TCA C.-GA  CTA GCG G~  AAT  GAG CAG  TAC  "TTC GGG (~A GGC  ACG  CGG CTC CTG GTG CTA 
A  S  S  S  G  L  A  E  N  E  Q  Y  F  G  P  G  T  R  L  L  V  L 
4 3  GCCAGCAGC  TCA GGA CTA GOG C-~8  AAT  GAG  CAG  TACTTC GGG  OCA  GGC ACG  OGG  CTC  CTG G'rG CTA 
A  S  T  T  T  S  R  Y  Q  E  T  Q  Y  F  G  P  G  T  R  L  L  V  L 
NP7  GCCAGCACC  ACC  ACCT~r CGG TAC  CAA  GAG ACC CAG TAC "rrc ~_.~ CCA GGC ACG CC~ CTC CTG GTG CTC 
E 
GaG  V~  1.1a/DI3  2.1/J1~2.1 
E 
GaG  V~,  1.1a/D~  2.1/J~ 2.1 
E 
GaG  V~  1.1a/D[~  2.1/J~ 2.1 
E 
GaG  V~  1.1a/D[3  2.1/J~2.1 
E 
G~  V~  6.5/D~  2.1/J~ 2.5 
B 
Clone  Vc~  J(x  C(x 
F  C  A  A  R  G  F  GN  F  N  K  F  Y  F  G  S  G  T  K  L  N  V  K  P  N  I 
37  TrCFGTGC.A  GOCOC---~GGGTFCGC-:~AACTI'CA,'a,CA,~,TITTACTTTGC-~TCTGGG~~T~A~T  ATC  Vu  15.1/J(~AC24 
F  C  A  A  R  G  F  G  N  F  N  K  F  Y  F  G  S  G  T  K  L  N  V  K  P  N  I 
72  TI'CTGTC,-,-,-,-,-,-,-,-,~A  GC~OGGGGG'I"FCGGGA/~CTTC/~,CAAATI'rTACTTIGC~TCTC_.~G~~T~A~T  Arc  Vet  15.1/J~ AC24 
F  C  A  A  R  G  F  G  N  F  N  K  F  Y  F  G  S  G  T  K  L  N  V  K  P  N  I 
73  TI'CTGT~  GCCCC-~GGGTTCGGGAACTTCAACAAATFrTACTFFGGATCT~ACCAAACTC~TGTA~A~T  ATC  V(x  15.1/Jc( AC24 
F  C  A  E  S  S  S  G  G  Y  N  K  L  I  F  G  A  G  T  R  L  A  V  H  P  Y  I 
43  TFCTGTGCA  GAGAGTTCTTCTGGTGGCTACAATAAGCTGATrTTFGC-~GCAGGGAOCAGGCTG~GTA~ATAT  ATC  Ve  15.1/IGRJc(08 
F  C  A  L  S  G  N  N  D  K  L  I  F  G  T  G  T  R  L  Q  V  F  P  N  I 
NP-7  TrCTGTGC"F  CTGAGTGGAAACAACGACAAGCTCATCTTTGGGACTGGGACCAGATTACAAGTCTTr~A~T  ArC  Vc~  22.11Jet 1 
F  C  A  P  Q  (3  N  Y  G  Q  N  F  V  F  G  P  G  T  R  L  S  V  L  P  Y  I 
TI'CTGTGCT  OCCCAGGGGAACTATGGTCAGAATTB'GTCTITGGTCCCGC,~AOCAGATIGT(X;GTGCTGCCCTAT  ArC  V~t  22.1/J(x 33 
Figure 1.  Nucleotide and amino acid sequence and alignment of (A) TCR [3 V-(D)-J regions and (B) TCR 0~ chain V-J regions. For each clone are 
indicated the names of the corresponding  VI3,  J[3, vct, and fix genes. Only the last nine nucleotides encoding for the last three amino acid residues of each 
V segment are shown, followed by the junctional regions. The random TdT addition nucleotides 5' and 3' to the diversity region are underlined.  Amino 
acids are indicated by the single letter code, numerated  according  to Chothia et al. (36). Amino acids in bold are the common motifs in the CDR3 re- 
gion. Several sequences from 5 to 10 bacterial colonies were performed for each chain, and repeated analysis using mRNA obtained several months apart 
gave identical results. (A) In the CDR3 of all chains at position  101 corresponds a Glu residue (E), which is flanked at positions 100 and 102 by polar but 
uncharged  amino acids Ash (N), Gln (Q), or Thr (7). JI3 2.1 was used by all the clones, except clone NP-7, which encoded for the full germline JI3 2.5. 
(B) The CDR3 of the oL chains of clone NP-7 revealed a common motif Gly-Asn (GN) entirely template dependent  in Vct22/J0~33, whereas the gly was 
encoded by the N-nucleotide addition  and the Asn was template dependent  in V(x22/J~l.  Snrfilar GN motif was also shared by the CDR3 of the sister 
clones 37, 72, and 73.J regions were named accordingly to reported sequences; J(xC24 (50), IGP, Ja08 (25), Jcd (51), andJc133 (52). These sequence data 
are available from EMBL/GenBank/DDBJ under accession numbers: X84687, X89751, X89752, X89753, X89754, X89809, and X89860. 
clones 37,  72,  73,  and  NP-7;  the direct sequencing  of the 
only amplified Vo~ and V[3 products gave identical results to 
the AnPCR. analysis. 
Fine Epitope Mapping of  TPO  535-551-specific  T  Cell 
Clones.  The fine specificity of antigen recognition among 
the T  cell clones was  examined  using a  nested  set  of eight 
overlapping 12-arnino  acid synthetic peptides spanning res- 
idues  534-552  of the TPO  molecule  (GLDPLIRGLLAR- 
P,,PAKLQV),  each  advancing  one  amino  acid  in  the  se- 
quence.  We  expected  that  the  unusual  and  exceptionally 
restricted  TCI:L  usage  (that  is,  TCP,.  chain  sharing)  might 
produce  an identical or very similar pattern  of recognition. 
On  the contrary,  as shown  in Fig.  3,  three  distinct profiles 
of recognition of the TPO  535-551  region were identified. 
TPO  536-547  and  539-550  peptides  were  recognized  by 
clones  37,  72,  and  73,  but  were  not  recognized  by  clone 
43,  which was specific for the 541-552  region of the TPO 
molecule.  Clone  NP-7  recognized  the  region  TPO  537- 
352  Restricted TCk  Recognize Multiple Human SelfEpitopes 552,  but  unlike clones 37,  72,  and  73,  failed to  recognize 
TPO  536-547. 
T  Cell  Clones Recognizing  TPO  535-551  in  Association 
with HLA-DQ.  In a previous report (16) we excluded the 
DR  antigens as the restricting element,  but could not de- 
fine whether DQ6  and/or DP2  molecules were active ge- 
netic  restriction elements.  Since  it has  been  reported that 
nonself as  well  as  self-epitopes may be  recognized in  the 
context of two different HLA molecules in the same indi- 
vidual  (27-29),  it was  of interest  to  fully characterize  the 
MHC  restriction  of the  clones.  The  T  cell  clones  were 
cocultured  with  fixed  EBV-transformed  B  cell  lines  of 
known MHC  haplotypes, with or without exogenous pep- 
tide 535-551.  The  EBV-transformed B  cell lines were  se- 
lected to be homozygous either for DQ6  or for DP2,  dif- 
fering for all the  other HLA antigens with  the  autologous 
APC.  The  results (Fig. 4)  indicate that none  of the  clones 
Figure 2.  T cell clone 43 was 
analyzed by RT-PCR  incorpo- 
rating  [32p]dCTP, with  a panel 
of V[3  and  V0t  family-specific 
primers.  PCR  products  ranged 
from ,'-'170 to 300 bp and from 
300  to 500 bp for the  [3 and a 
chain,  respectively.  Products 
were run on 2% agarose gel and 
visualized at UV light. The gel 
was then  dried and exposed for 
24 h on autoradiograph. This re- 
sult is representative of three dif- 
ferent experiments. 
responded  to  the  TPO  peptide  535-551  when  presented 
on EBV 9036,  which  expressed DPB1*02012,  whereas  all 
clones recognized the TPO peptide 535-551  in the context 
of the DQBI*0602/DQA*0102  molecule (EBV 9013).  Fur- 
ther studies of biotinylated peptide binding have shown that 
DQBI*0602/DQAI*0102  binds the  TPO  peptide 535-551 
whereas Dtk2 and DR3 do not (Quaratino, S., unpublished 
observations). Inhibitory experiments performed using anti- 
DQ,  (SVLB4)  anti-DP  (B7/21),  and  anti-DR  (Ta114.1) 
mAbs confirmed that all the  T  cell clones are restricted by 
DQ molecules (data not shown). Thus, the epitope microhet- 
erogeneity we  observed was  not due to presentation of the 
same peptide in the context of different HLA molecules. 
Recognition  of the  Autologous  TPO-transfected EBV  Cell 
Line.  tkecendy we  reported that  clone  37  recognizes an 
autologous EBV cell line transfected with the cDNA encod- 
ing TPO  and expressing TPO  at the cell surface  (26).  We 
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Figure  3.  Fine  specificity of 
TPO  535-551--specific T  cell 
clones 37, 72, 73, 43, and NP-7. 
Eight overlapping synthetic pep- 
tides of 12 amino acids spanning 
from residues 534 to 552 of hu- 
man  TPO  were  used to  define 
the minimum epitope of each T 
cell clone. All T cell clones were 
tested at least twice, and all the 
experiments  showed  a  similar 
profile of responsiveness. Figure  4.  HLA  genetic  re- 
striction of T cell clones 37, 72, 
73, 43, and NP-7.  Homozygous 
EBV-transformed  B  cell lines 
9036 and 9013 expressing  identi- 
cal  DP2  or  DQ6,  respectively, 
with  the  autologous APC  were 
chosen to  define if the  genetic 
restriction element was  DP2  or 
DQ6.  The  EBV  cell line 9036 
expressed  DPBI*02012  and 
DQB*0502/DQA*0102,  whereas 
the  9013  cell  line  expressed 
DPBI*0402  and  DQBl*0602/ 
DQA*0102.  EBV  9036 1)P2  + 
failed to present the  TPO  535- 
551  peptide  to  all  the  clones, 
whereas EBV 9013 DQ6 ~ pre- 
sented  the  peptide  to  all  five 
clones  with  comparable effi- 
ciency  to  the  autologous  EBV 
cell line. 
compared the capacity of this TPO-transfected autologous 
EBV cell line to stimulate clones 37, 43, and NP-7.  Clones 
43  and NP-7 did not recognize the autologous TPO-EBV 
cells, whereas  in  the  same  experiment,  clone  37  did  (Fig. 
5). As expected, all the clones responded to the exogenous 
peptide  535-551  presented  by  the  autologous  EBV  line 
(untransfected)  and  they  had  previously  responded,  al- 
though to a different extent, to exogenous TPO  presented 
by PBL  (16).  These results imply that the TPO-transfected 
EBV  cells presented on the cell surface the epitope recog- 
nized  by  clone  37,  but  not  the  epitopes  recognized  by 
clone  43  or  clone  NP-7.  These  data  demonstrate  that 
clones 37 and 43, which differ in the TCR Jet region only, 
recognize  two  completely different epitopes,  only  one  of 
which is presented after endogenous processing. Compared 
with the results shown in Fig. 3, only a peptide identical or 
very similar to TPO 536-547 was presented, upon endoge- 
nous presentation, in the region 535-551. 
Recognition of the Autologous TEC.  Although the results 
obtained  with  the  autologous  TPO-transfected  EBV  cell 
line were intriguing, there was  still the possibility that the 
EBV cells endogenously processing TPO were generating a 
different epitope repertoire than TEC.  To evaluate the po- 
tential in vivo situation, we repeated the experiment using 
the  autologous TEC  to  stimulate the  T  cell clones in  the 
absence  of exogenous  antigen.  As shown  in  Fig.  6,  clone 
43  did not respond to TEC,  whereas it did respond to the 
exogenous TPO  presented by PBMC.  In the same experi- 
ment,  clone  37,  on  the  contrary,  expressed a  marginal  (if 
any)  response to  exogenous TPO  processed and presented 
by PBMC  whereas  it was  well stimulated by TEC,  con- 
firming that different TPO  epitopes are displayed upon ex- 
ogenous  versus  endogenous  processing.  This  epitope  can 
also be considered as cryptic, since it is an epitope available 
for recognition only under restricted conditions, in this case 
by the TEC expressing class II acting as nonclassical APC. 
EBV + "17 
EBV-CAT + T' 
EBV-TPO  + T 
EBV + TPO 535-551  + T  ' 
Clone37  Clone 43  Clone NP-7 
0  5  10  15  20  5  10  t5  0  25  50  75  100 
3H-thymidine incorporation c.p.m. ( x  10"3) 
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Figure  5.  Recognition  of au- 
tologous  TPO-transfected  EBV 
cell line by T cell clones 37, 43, 
and NP-7. Only clone 37 recog- 
nized  the  endogenously  pro- 
cessed TPO. Clones 43 and NP-7 
recognized  the  peptide  TPO 
535-551 added exogenously, but 
failed to recognize the  endoge- 
nously  processed TPO.  These 
results suggested that an epitope 
corresponding  to  the  peptide 
536-547 was presented upon en- 
dogenous  processing.  Results 
shown  are  from  single experi- 
ments, and they  are representa- 
tive of those seen in three differ- 
ent assays. PBMC + T 
PBMC + micros + T 
PBMC + TPO micros + T  1  l 
TEC + T 
TEe only 
0  1000  2000  3000  4000 
3H-thymidine  incorporation  (c.p.m.) 
Figure  6.  Recognition  of endogenously and  exogenously processed 
TPO by T cell clones 37 and 43. (Striped bars) Clone 37; (empty bars) clone 
43.  Autologous PBMC  were  used to  present purified microsomes of 
CHO cells untransfected or transfected with TPO (16). Autologous TEC 
induced proliferation of clone 37  only, whereas exogenously processed 
TPO by PBMC was recognized by clone 43 and not by clone 37. 
Discussion 
The analysis of self-reactive T  cells has been  one  of the 
major targets  of research  in  autoimmunity  during  the  last 
few  years.  These  studies  have  aimed  to  define  the  three 
specific elements involved in self-recognition;  much effort 
has been placed into the characterization  of immunodomi- 
nant self-epitopes and TCR  usage (11-13,  30).  The aim of 
these  experiments  is  to  understand  the  general  features 
common  to all autoimmune  diseases.  Many attempts have 
been made to determine whether self-reactive T  cells have 
a  restricted  TCR  Vet  or V[3  usage  (11,  24,  31-33),  since 
restricted  TCR  usage  or  detection  of  conserved  motifs 
could  suggest  dominant  self-epitope  recognition  (34). 
There  is  evidence  that the  CDR3  of the  TCR  is directly 
involved in epitope recognition  (35-37),  and this has led to 
the notion  that T  cells expressing conserved CDR3  motifs 
are prone to recognize identical epitopes (38, 39). 
Studies  of T  cell  clones  specific  for MBP  (13,  33)  and 
sperm whale myoglobin  (40)  have demonstrated  that mul- 
tiple combinations ofTCR  Vot/Jet paired with an identical 
or similar TCR  [3  chain  may yield a  nearly identical  epi- 
tope  specificity.  It  is interesting  to  note  that  a  conserved 
CDR3  motif was observed in T  cell clones from Lewis rats 
with  experimental  acute  encephalomyelitis  reactive  to  the 
MBP  peptide  87-99  (38).  The  finding  that  this  conserved 
motif was  also  observed  in  a  large proportion  of TCR  [3 
transcripts ofT lymphocytes infiltrating plaques from multiple 
sclerosis patients was thus considered to be strong evidence 
that infiltrating T  cells recognized the same MBP peptide (34). 
Our  report  demonstrates  that  T  cell  clones  sharing  the 
same TCR  [3 and Vet but differing in the Jet are able to rec- 
ognize  contiguous  but  different  epitopes  of the  same self- 
molecule. Thus, even with restricted TCR  V region usage, 
multiple  epitope  recognition  still  occurs.  It is plausible  to 
envisage that T  cell clones may share identical  [3  chains  at 
the  nucleotide  level, since the  [3 locus rearranges before et 
(41);  thus  two  different  clones  from a  common  precursor 
may rearrange  distinct  et chains  and emerge from the  thy- 
mus.  The  TCR  sequencing  of other  TPO-specific  T  cell 
clones  established  from  the  same  individual  showed  that 
different et and 13 chains are used (data not shown). 
Regarding  clone  NP-7  in  which  we  detected  two  et 
chain  messages,  it  has been  hypothesized  that  clones  ex- 
pressing two o~ chains may be involved in the pathogenesis 
of autoimmune  diseases (2, 3).  Since the overall expression 
of the  self-reactive  TCR  is  significantly  reduced  by  the 
presence  of a  second  TCR,  such  a  decreased  expression 
may reduce  the  specific avidity of these  cells for self,  thus 
allowing their positive selection in the thymus (3).  Another 
aspect of double TCR  expression is that in clones express- 
ing two functional TCR,  one of which may recognize self, 
the activation of the T  cell via engagement of the other re- 
ceptor  may lead  to  an  "unwanted"  activation  against  self, 
leading to autoimmunity  (2, 3). Although we do not know 
whether the two (x chains  are expressed at the cell surface, 
clone  NP-7  may be useful to test this hypothesis,  by sepa- 
rately cotransfecting the TCR  et with the TCR  [3 chain in 
a  suitable  TCR-negative  cell  (42).  The  marked  sequence 
similarity suggests that antigenic pressure, rather than a ran- 
dora  event,  selected  its  two  et  chains,  and  indicates  that 
both chains might be involved in self-recognition.  If this is 
the case, and no second specificity is found for clone NP-7, 
it  would  suggest  that  the  two  expressed  TCR,  to  escape 
thymic selection, are both of low affinity for self (3). 
Different  hypotheses  have  been  evoked  to  explain  pe- 
ripheral  activation  of self-reactive T  cells.  It has been sug- 
gested that a bystander or unwanted  activation of self-reac- 
tive T  cells could be induced  by superantigens  engaging T 
cells in a V[3-specific fashion (23) or via molecular mimicry 
(43); recently, it has been demonstrated that T  cells specific 
for a self-epitope may recognize peptides of viral or bacterial 
origin  (44,  45).  A  theory  that  can  simultaneously  address 
peripheral  activation  and  lack of central  tolerance  is based 
on  the  existence  of  a  "cryptic  self-epitope  repertoire:" 
epitopes hidden during thymic education may become evi- 
dent  in  the  periphery  upon  restricted  conditions  such  as 
different antigen loading or type of cells acting as APC  (6, 
7).  That  a  cryptic  repertoire  exists  has  been  described  in 
several animal models (46); this theory has also been useful 
to explain the process ofepitope spreading (8), and recently 
has been shown in a human system (47). 
A  central finding of our study is that two different types 
of APC  or antigen  loading produce  functional  differences 
in the self-peptides displayed in their HLA grooves. It indi- 
cates  that  cryptic  epitopes  of a  disease-related  autoantigen 
may  be  generated,  and  more  importantly  recognized  by 
some, but not all,  in vivo-activated, antigen-specific T  cell 
clones  (Figs.  5  and  6).  Our  results  highlight  another  re- 
markable  feature  of the  cryptic  (that  is,  only  presented 
upon  endogenous  processing)  epitope.  Indeed,  the  close 
analysis of the data reported in Fig. 3  indicates that peptide 
536-547,  which  closely corresponds  to the  natural  cryptic 
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alent  molar  concentration  of peptide  TPO  535-551,  ex- 
tremely efficient in activating the sister clones 37,  72, and 
73.  The  epitope  recognized by  the  T  cell  clone  37  was 
studied  in detail  using truncated  peptides  at  the  NH 2 and 
COOH  termini  of peptides  536-547 and 539-550,  to ex- 
plain the peculiar pattern of responsiveness observed in Fig. 
3; the  results  are detailed  elsewhere  (48).  It has been sug- 
gested that nonprofessional APC such as class II--expressing 
TEC,  could act as APC  (5),  and via endogenous process- 
ing, display a self-epitope profile different than the one dis- 
played  after  antigen  uptake  and  by  reprocessing  APC  in 
PBMC  (46).  A  few years ago, we demonstrated that TEC 
could be specifically recognized by self-reactive T  cells  (15). 
Subsequently,  we have  shown that many TPO-specific T 
cell  clones  were  also  stimulated  by autologous  thyrocytes 
(16).  More  recently,  we have  demosntrated,  using TPO- 
and thyroid-stimulating hormone receptor-transfected EBV 
cell lines,  that  processing  and  presentation  of membrane- 
associated self-antigens  can occur (26,  49).  The results  re- 
ported  in  this  study  demonstrate  that  a  cryptic  epitope  is 
displayed by TEC  and recognized in vivo by autoreactive 
T  cells (Fig. 6). We have also found other T  cells at the site 
of the  disease  that recognized the  autoantigen  only when 
presented  by  professional  APC,  as  clone  43  recognized 
TPO  presented  by PBMC  and  not by TEC.  We  do not 
know which of the  two types of self-reactive T  cells may 
initiate the autoimmune process, but we favor the hypoth- 
esis  that  the  primary  event  is  the  recognition  of the  self- 
processed epitope,  once the thyroid epithelial  cells acquire 
antigen-presenting  capability (5,  15,  17).  That recognition 
of the cryptic epitope may represent a primary event is also 
supported by the evidence that this epitope is extremely ef- 
ficient in activating the sister clones 37,  72,  and 73,  com- 
pared to peptide 535-551. Cells such as clones 43 and NP-7 
may intervene  when  the  autoantigen,  released  after  tissue 
damage, is processed by professional APC, and may corre- 
spond to a second phase of seK-recognition,  that may rep- 
resent epitope spreading in human autoimmunity. 
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